Physician profile
Himax Patel
NPI 1790309227
$2,895.11
in general payments reported to CMS, 2019-2025
25 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.77 · 2023: $372 · 2024: $1,256 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,774 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,773.79 |
| Education | $100.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $925.90 | 2023-2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $257.39 | 2024-2025 | Watchman Flx, Resonate El Icd Vr |
| Abiomed | $237.71 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $235.61 | 2023-2025 | |
| Cvrx, INC. | $228.94 | 2024 | Barostim Neo System |
| Abbott Laboratories | $219.30 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Gallant, Aveir |
| Stryker Corporation | $180.30 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.06 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $51.51 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $50.96 | 2024 | Arcalyst |
| Recor Medical INC | $45.01 | 2025 | Paradise Ultrasound Renal Denervation System |
| Inari Medical, INC. | $42.25 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $40.22 | 2023-2025 | Guideliner |
| Edwards Lifesciences Corporation | $30.50 | 2025 | Sapien 3 Ultra Resilia |
| Terumo Medical Corporation | $22.51 | 2024 | Glidesheath Slender, Angio-Seal |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $21.18 | 2025 | Cardiva Vascade 6/7f Vcs |
| Scilex Pharmaceuticals INC. | $20.77 | 2022 | |
| Pfizer INC. | $20.40 | 2025 | |
| Heartflow, INC. | $19.67 | 2025 | |
| Scpharmaceuticals INC. | $19.40 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.82 | 2024 | |
| Asahi Intecc USA, INC. | $18.42 | 2024 | Peripheral Vascular |
| Abbvie INC. | $18.00 | 2025 | |
| Biotronik INC. | $15.50 | 2023 | Orsiro Mission, Nhancer Rx |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Himax Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.